Progressive fibrosis of the interstitium is the dominant final pathway in renal destruction in native and transplanted kidneys. Over time, the continuum of molecular events following immunological and nonimmunological insults lead to interstitial fibrosis and tubular atrophy and culminate in kidney failure. We hypothesize that these insults trigger changes in DNA methylation (DNAm) patterns, which in turn could exacerbate injury and slow down the regeneration processes, leading to fibrosis development and graft dysfunction. Herein, we analyzed biopsy samples from kidney allografts collected 24 months posttransplantation and used an integrative multi-omics approach to understand the underlying molecular mechanisms. The role of DNAm and microRNAs on the graft gene expression was evaluated. Enrichment analyses of differentially methylated CpG sites were performed using GenomeRunner. CpGs were strongly enriched in regions that were variably methylated among tissues, implying high tissue specificity in their regulatory impact. Corresponding to this methylation pattern, gene expression data were related to immune response (activated state) and nephrogenesis (inhibited state). Preimplantation biopsies showed similar DNAm patterns to normal allograft biopsies at 2 years posttransplantation. Our findings demonstrate for the first time a relationship among epigenetic modifications and development of interstitial fibrosis, graft function, and inter-individual variation on long-term outcomes.
Introduction
Although kidney transplantation (KT) is the preferred treatment for patients with end-stage renal disease (ESRD), the long-term survival rate of the renal allograft remains a challenge (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) , mainly as consequence of death with a functioning graft and intrinsic chronic renal allograft dysfunction (or CRAD) (1) (2) (3) (4) (5) 11) . CRAD is timedependent, progressive, irreversible, and currently diagnosed late in its course. Its pathogenesis is multifactorial and comprises both immune and nonimmune mechanisms with successive insults to the graft culminating in interstitial fibrosis and tubular atrophy (IFTA) and progressive loss of graft function. Its pathogenesis has not been fully elucidated and existing therapy is not effective in improving renal transplant function.
Studies aiming at understanding progression to IFTA post-KT have mostly been limited to single-dimensional approaches. In order to better understand the injury mechanisms occurring in KT, integration of molecular measurements of large datasets from different experiments and technologies would be required. Evaluation of tissue graft DNA methylation (DNAm) patterns and its effect on molecular pathways leading to decrease in graft function has not been done yet. Methylation of DNA at cytosine bases of the CpG-rich sites prevents downstream gene expression (GE) either by inhibition of binding of transcription factors directly or by recruiting proteins such as histone deacetylases (12, 13) . DNAm patterns in normal tissue development and in disease phenotypes have long been established (14, 15) . There are also an increasing number of reports showing the impact of DNAm in renal diseases (16) (17) (18) (19) . Environmental factors influence DNAm patterns, which leads to change in GE profiles and cause disease phenotype downstream (20, 21) . For instance, the role of DNAm in development of regulatory T cells, B cell maturation, B cell activation, and macrophage polarization has been reported (22) (23) (24) . The inflammatory environment has been found to influence DNAm patterns/epigenome (25, 26) . Thus, chronic diseases may set the stage for a chain reaction of events where epigenetic modifications and long-lasting organ insults influence each other, leading to disease progression. Therefore, it is of utmost importance to study and understand these systemic modifications occurring during disease progression, which might not be exclusive to fibrosis development in kidneys but likely of importance for other solid organs as well.
DNAm studies in chronic kidney disease (CKD) show the role of methylation in an abnormal wound healing process that results in fibrogenesis (16, (27) (28) (29) . In transplantation, only a few studies were done addressing DNAm changes (25, 27, (29) (30) (31) . However, these studies mostly used reductionist systems limited to one or few gene sets and were limited to mouse and cell-based models. Long-term graft deterioration can be considered a variant of CKD (32) , sharing common events of decline in kidney function and renal fibrosis. Oxidative stress may be the mechanism responsible for toxic effects and IFTA caused by immunosuppressive drugs (33) . Furthermore, oxidative stress is one of the most important components of the ischemia/reperfusion process after KT and increases with graft dysfunction. Also, the fundamental mechanism of interstitial fibrosis is the imbalance of extracellular matrix metabolism and abnormal accumulation via interaction of various inflammatory cytokines. A relationship between inflammation and fibrosis progression has been previously described. Herein, we hypothesize that the renal allograft is in an environment where oxidative stress and an unresolved inflammatory setting trigger changes in DNAm patterns of the allograft, which in turn could exacerbate injury and slow down the recovery and healing processes, eventually leading to fibrosis development and graft dysfunction. However, understanding such a complex, multifactorial pathogenetic process requires a multidimensional systems approach. We thereby incorporated integrated analyses of tissue-specific global kidney graft DNAm, downstream GE, and miRNA pattern changes in samples with IFTA and declining graft function, stable functioning allografts without fibrosis, and pretransplant donor kidney biopsies. Using this approach, a critical role of epigenetic modifications impacting molecular pathways leading to progression to IFTA with subsequent graft loss in graft biopsies from KT recipients was identified.
Methods

Enrolled cohort
A total of 99 protocol biopsy samples from 95 kidney transplant recipients of deceased donor grafts were included in the study. Patients were enrolled between May 2004 and November 2010 as part of a prospective multicenter study (UVA 14849, VCU#HM11454). Sample details are given in the Supplementary Methods section and Table S1 . Centralized histological evaluation was performed by two blinded pathologists using Banff classification (34) (35) (36) (37) (38) . Pathologist's interpretation was determined when critical disagreement in diagnosis was observed, following the algorithm reported by Elmore et al (39) .
Study design
The overview of study and analysis work flow is shown in Figure 1 . Two sets of protocol kidney biopsy samples were analyzed, one posttransplant (≥24 months Post-KT; n = 59) and one pretransplant (Pre-KT; n = 40). Each set included one arm of transplants with normal function and nonfibrotic tissue (estimated glomerular filtration rate [eGFR] slope over time stable and not declining, IFTA ci ≤ 1, ct ≤ 1; stable functioning allograft with no or minimal IFTA [NFA] samples [n = 18, training set; n = 11, validation set] and one arm with declining function and fibrotic tissue [eGFR slope over time negative], IFTA ci ≥ 2, ct ≥ 2; IFTA, [n = 18, training set; n = 12; validation set]). The eGFR slope was calculated from time of transplantation to time of biopsy retrieval using values at time points described in Table 1 . Five sets of paired biopsies (Pre-KT and 24-months post-KT, with three progressing to IFTA, two keeping normal graft function) were included. The set of Pre-KT samples was classified into 20 IFTA samples and 20 NFA samples according to their histology in biopsies taken >24 months after transplantation and the corresponding eGFR slope calculated over this posttransplant period.
DNA/RNA arrays
DNAm arrays were done using Infinium HumanMethylation450K BeadChip array (Illumina, San Diego, CA). MiRNA expression and GE analyses were done using GeneChip â miRNA v4.0 array (Affymetrix, Santa Clara, CA), and GeneChip â HG-U133A v2.0 (Affymetrix) (GEO accession number GSE53605) respectively. (See Supplementary Methods for further description.)
Data analysis and quality control
Bioconductor packages minfi (scanned methylation arrays) and oligo (scanned miRNA and GE) were used for initial procurement of respective data (40) (41) (42) . The details of the analyses and quality control parameters are furnished in the Supplementary Methods section.
For each of the above three analyses, the groups of interest, IFTA and NFA, were compared using a moderated t-test using the limma (43) Bioconductor package (44) . Probe sets were considered significant when the false discovery rate (FDR) by Benjamini and Yekutieli method (45) was <0.01. For methylation arrays, an additional filter for CpG sites having a jDbj ¼ jb IFTA À b NFA j ! 0:20 was used.
Enrichment analysis for methylation data
The enrichment analyses were performed using GenomeRunner (46) to test whether up/downregulated CpG sites, both in the gene and nongene regions, were enriched in any specific class of (epi)genomic annotations, as compared with randomly selected CpG sites from all 450K CpGs on the Illumina Infinium array.
Integrative analysis
Initially, the GE data (Dataset 2) and the miRNA data (Dataset 3) were separately integrated with DNAm data (Dataset 1) by matching the gene symbol of each significant probeset to the UCSC Reference gene name field in the annotation data.
For DNAm and GE integration, the CpGs were listed together with their directionalities and then the data were sorted according to the direction of expression of each gene and associated CpGs. The data were categorized into four subsets depending on the direction of GE and DNAm: (1) genes with associated CpGs with negative trend of correlation, (2) genes with associated CpGs with positive trend of correlation, (3) genes with associated CpGs that were bidirectional, and (4) genes without associated CpG sites. We proceeded with further steps using the subset with negatively correlated CpGs ( Figure S5 ) (Integration Dataset 1).
Additionally, to support our analyses we examined the relationship between DNA methylation levels and gene expression using an approach previously described (47) and also based on additional reports (48) . First, the differentially expressed genes between CRAD and NFA groups with low versus high differential expression were defined according to . Dme CpG sites were mapped and analyzed using directionality of methylation for evaluating overall affected genes and associated pathways. DNA methylation from preimplantation biopsies (including five paired samples (three IFTA and two NFA after 24 months post-KT)) and NFA and IFTA DNA methylation data were used for unsupervised cluster analysis. Two datasets resulted from this initial step: dataset A and dataset B, respectively. Section B: 21 post-KT samples for which paired GE and miRNA data were available were used for integration analysis. The section A experiments resulted in datasets 1, 2, and 3 from methylation (Human Infinium 450K arrays), GE (GeneChip â HG-U133A v2.0) and miRNA (GeneChip â miRNA v4.0 array) expression arrays, respectively, which were further used for integration analysis as shown in Figure 5 . Section C: Following the integration analysis genes from important pathways/miRNA:mRNA interactions were validated using coexpression analysis in an independent set of 23 samples. CRAD, chronic renal allograft dysfunction; FDR, false discovery rate; IFTA, interstitial fibrosis and tubular atrophy; NFA, stable functioning allograft with no or minimal IFTA; qPCR, quantitative polymerase chain reaction. For miRNA and DNAm, we identified all the differentially methylated (Dme) miRNAs and further filtered those that were Dme in the transcription start site. Within this subset of miRNAs, only those that showed negative correlation in terms of expression (Integration Dataset 2) were selected for further validation.
We then used Integration Dataset 2, and an in silico prediction list of targeted mRNA (Dataset 4) with a prediction score >75 from databases available online (49,50) was established. We then compared this Dataset 4 with Integration Dataset 1 and Dataset 2 to obtain an integrated set of data where Dme miRNA targeted GE data were obtained. This integration Dataset 3 was used for pathway analysis and validation studies.
Principal component analysis and unsupervised cluster analysis
CpG sites were filtered to remove background noise (details of the parameters used are elaborated in the Supplemental Methods section) and a variance-based filter was applied for the remaining 335 212 CpG sites. Furthermore, all the CpG sites having a variance at or above the 95 th percentile were retained (16 761 CpG sites) and were subjected to principal component (PC) analysis and the first and second PCs were plotted against each other. The same 16 761 CpG sites were used when performing average linkage hierarchical clustering, where Pearson's correlation was used as the distance.
Results
Patients and samples
Characteristics of donors and recipients are shown in Table 1 . There were no differences in biopsy collection time between post-KT IFTA and NFA (biopsy collection time = 31.3 AE 6.5 vs. 28.3 AE 2.6 months post-KT, pvalue = 0.32). No significant differences were observed between groups except for the differences in eGFR values between IFTA and NFA groups. Histological characteristics of samples used are shown in Table 2 . No statistical differences were observed between IFTA samples when subclassified as training and validation set.
Distribution of differentially methylated CpGs across genomic and regulatory features A total of 17 292 CpG sites corresponding to 5935 genes and spread across CpG islands (10.6%), island shores (24.6%), island shelves (9.8%), and open sea (54.9%) ( Figure S1A ) were Dme post-KT in kidney biopsies with IFTA (n = 18) when compared to NFA samples (n = 18). Figure S1B ]). The numbers of hypo-and hypermethylated CpGs were similar. A fraction of these genes (14.8%) were represented by both hypo-and hypermethylated CpG sites ( Figure S1C ). Dme CpGs in IFTA samples showed that both hyper-and hypomethylated CpGs were highly enriched in protein-coding gene bodies (Figure 2A) . Moreover, all the Dme CpGs were strongly enriched in regions that are variably methylated among tissues, implying very high tissue specificity in their regulatory impact and interestingly, enrichment analysis to tissue-specific enhancers showed that the hypermethylated CpGs were strongly adult kidney specific while the cg1: 0 (0%) cg1:0 (0%) cg2: 0 (0%) cg2:0 (0%) cg3: 0(0%) cg3: 0 (0%) C4d
C4d1: 0 (0%) C4d1: 1 (8.3%) C4d2: 0 (0%) C4d2: 0 (0%) C4d3:0 (0%) C4d3: 0 (0%)
All values expressed as n (%). There was no significant difference between the two study groups. IFTA, interstitial fibrosis and tubular atrophy; TG, transplant glomerulopathy.
hypomethylated CpGs were specific to immune cells (Figure 2B) . Additionally, the representation of the Dme CpGs across the chromosomes based on general chromosome representation pattern of CpGs on the Illumina bead array was similar for all of the 22 chromosomes Figure S2 ). However, enrichment analysis revealed that hypermethylated CpGs were found to be most significantly enriched in the p arm of chromosome 7 (p-value = 1.08E-140) (Figure 2C ) (Tables S1.1, S1.2).
Hypo-and hypermethylated CpGs across genes and associated molecular pathways In this section, the overall distribution of Dme CpGs across genes was evaluated. As Dme CpG sites were mapped, those genes presenting multiple Dme CpGs (Dataset A, Figure 1 ) were used to explore the main pathways (Ingenuity pathway analysis [IPA] [www.ingenu ity.org] [51] ) that may be affected by the aberrant DNAm patterns identified in the IFTA samples when compared with NFA. The analyses of the hypomethylated CpGs showed that the top canonical pathways were related to the immune system ( Figure 3A ) including CD28 signaling in T helper cells (p-value = 4.83 E-10; activation Zscore = 5.947; BCL10, ACTR3, CALM1, CD80, CD86, CD3E, ZAP70, VAV1, and NFKBIE) and dendritic cell maturation (p-value = 1.52 E-03 Z-score = 6.403; CCR7, CD80, CD86, CD1D, CSF2, HLA-A, HLA-C, HLA-DMA, IL23A, and IL1B). The molecular functions of the hypomethylated genes were related to immune cell trafficking, lymphoid tissue structure and development, cellcell signaling interaction for activation, migration, and homing of leukocytes, and the top networks were those involved in cellular function, maintenance, cell-cell signaling, and molecular transport ( Figure S3 ). Top upstream regulators that were predicted to be activated (activation Z-score ≥8; p-value < 1.11E-13) in IPA analysis included IL-2, tumor necrosis factor, IL-1B, and NFKB. The hypermethylated CpG sites, on the other hand, were mapped to genes that were mostly involved in metabolism, especially of those that are important for maintaining stability, structure, and function of the kidney. The inhibited pathways included the aldosterone pathway in epithelial cells (p-value = 1.11E-02), platelet-derived growth factor signaling (p-value = 1.44E-04), and thrombin signaling (pvalue = 1.05E-04) ( Figure 3B ). Disease/toxicity functions of the genes hypermethylated included renal hypoplasia and glomerulosclerosis. The upstream regulators predicted to be inhibited included transcription factors such as TCF7L2, EBF1, SP1, F2, and HNF1A, all of them with functions associated with tubular epithelial cells and the kidney development/repair process.
Genes with dysregulation at two molecular levels: DNAm and gene expression Paired GE analysis was done (Dataset 2, Figure 1 ) for the same samples for which methylation studies were done (Dataset 1, Figure 1 ). Five thousand four hundred seventytwo probe sets corresponding to 3926 genes were significantly differentially expressed. Of these, 2366 genes were downregulated and 1587 genes were upregulated in IFTA. Around 31% of the differentially expressed genes showed Dme patterns at the gene level ( Figure 4A ). However, within this subset of genes there were genes (38%) for which there were both upregulated and downregulated CpGs. GE data, for which corresponding CpG methylation pattern matched (Integration Dataset 1, Figure 5 ), were analyzed using a comparison analysis in IPA. The canonical pathways related to immune response (activated state) including TREM1 signaling, actin-base motility by Rho, and dendritic cell maturation, while those related to nephrogenesis (inhibited state) including STAT3 pathway, plateletderived growth factor signaling, and growth factor signaling were seen to be dysregulated ( Figure 4B ). The top networks involving these dysregulated genes included developmental disorder, hereditary disorder, metabolic disease (score = 41) and cellular movement, hematological system development and function, and immune cell trafficking (score = 32) ( Figure S4 ). Additionally, the top disease functions were active injury to kidney (Z-score = 2.0, p-value = 1.46E-04) and showed involvement of genes such as C3AR1, STAT4, FCGR2A, and FABP1 ( Figure 4C) . Also, the relationship between DNAm levels and GE was evaluated using the R environment for statistical computing (as described in Methods) and a negative correlation (r = -0.76, p-value = 2.2e-16) between datasets was identified ( Figure S5 ).
Epigenetic regulation of gene expression: integration of DNA methylation, miRNA, and gene expression data DNAm data show that there were Dme CpGs located within the regulatory features of 81 different miRNAs. These results were compared with miRNA array data (Dataset 3, Figure 1 ) from the same samples that showed 86 different miRNAs being differentially regulated between graft biopsy groups (IFTA and NFA). A list of miRNAs that were upregulated in IFTA (miRNA microarray) and were hypomethylated at the TSS of gene (methylation array) was made. Only three miRNAs met the criteria, implying that DNAm is only one of the mechanisms that regulate expression patterns of the miRNAs (Integration Dataset 2, Figure 5 ). The three miRNAs were miR-150, miR-23a, and miR-762. Two of these three miRNAs were previously reported to be expressed in thick ascending limb of rat kidney (52) . In silico prediction of the targets for the three Dme miRNAs was done as described in Methods. The prediction lists (Dataset 4, Figure 5 ) were compared with available GE microarray data (Dataset 2, Figure 1 ) also done on the same IFTA and NFA biopsies. All the differentially expressed mRNAs that were predicted to be targeted for gene regulation by the three miRNA and those that match with the directionality of expression (since these miRNA are upregulated and suppress the GE of their targets) resulted in 85 different genes (Integration Figure 4 : Integration of ex vivo methylation and gene expression data. Of the total genes that were differentially expressed between IFTA and NFA allografts, a fraction of them were Dme upstream (A). IPA comparison analysis of the gene set filtered after integration of methylation and GE data and those genes associated with Dme CpG sites show canonical pathways related to immune system to be activated* while inhibited* related to organogenesis and metabolism (B). The genes involved actively participate in disease functions such as injury of kidney. (C) The GE legend shows the color key for (B) and (C), while the methylation data legend indicates methylation state for pathways shown in (B).*Orange in heatmap indicates activation of GE and hypermethylation for DNAm; blue in heatmap indicates inhibition for GE and hypomethylation for DNAm. Dme, differentially methylated; GE, gene expression; IFTA, interstitial fibrosis and tubular atrophy; IPA, ingenuity pathway analysis; NFA, stable functioning allograft with no or minimal IFTA.
Dataset 3, Figure 5 ). 21.2% of these genes were by themselves regulated directly by methylation (affected at the DNAm level and implying that they were part of Integration Dataset 1, Figure 5 ), and 52.9% of these genes, despite lacking associated Dme CpGs, could also be targeted and downregulated by these three miRNAs ( Figure 5 ). Functional analysis of the genes (Integration Dataset 3, Figure 5) showed kidney tissue-specific metabolic functions, especially in the tubular epithelial cells (BHMT2, CLCN5, G6PC, NTRK2, CLCNKB, PPM1H, and AHCYL1). Also, among them, inhibitors of transforming growth factor-b (TGF-b) signaling pathway (PPM1H, TGFB3) were identified to be downregulated corresponding to overall increase in TGF-b in the IFTA group. Top disease functions associated with these genes in IPA analysis show dysgenesis, cell death, growth failure, and hypoplasia (Z-score ≥ 2.621) ( Figure 6A ). It suggests that these genes contribute to renal tubule dysfunction and may be partly responsible for tubular atrophy and tubulointerstitial fibrosis.
Validation of results
After integration of DNAm and miRNA, the expressions of the three miRNAs that were Dme and differentially expressed from array assays were selected for validation Figure 5 : Data integration work flow. DNA methylation, miRNA and GE arrays were done from DNA and RNA samples isolated from the same IFTA and NFA renal allograft biopsy samples. Two-layer integrations were performed with DNA methylation (Dataset 1) and GE arrays (Dataset 2) and DNA methylation and miRNA arrays (Dataset 3). Each resulted in small datasets that were dysregulated at two molecular layers (Integration Sets 1 and 2, respectively).Then, gene targets were predicted in silico for the integrated miRNA dataset and these data (Dataset 4) were compared with ex vivo GE array data (Dataset 2) as well as GE array data filtered after integration (Integration Set 1). The overlapped dataset (Integration Set 3) is either associated with miRNA expression trend or with both miRNA and DNA methylation trend. The resulting integrated data were then subjected to miRNA-gene target coexpression validation using qPCR in training and validation sets. GE, gene expression; IFTA, interstitial fibrosis and tubular atrophy; NFA, stable functioning allograft with no or minimal IFTA; qPCR, quantitative polymerase chain reaction. [Color figure can be viewed at wileyonlinelibrary.com] using quantitative polymerase chain reaction (qPCR). To show coexpression of miRNA-mRNA target pairs (53), the best target pairs for these miRNAs, that (i) were predicted in silico (49,50) (as described in Methods), (ii) were also present in the GE array data from the same samples, and (iii) displayed the highest fold changes, were selected for validation. The miR-150-3p and its target CLDN8, miR-23a-5p and its target PDZRN3, miR-762 and its targets TGFBR3 and G6PC were all validated in both training and independent sets (IFTA = 12; NFA = 11). The miRNAs were all significantly upregulated in IFTA samples, while their respective mRNA target pairs were significantly downregulated ( Figure 6B and C). Additionally, genes resulting from the integrative approaches (Integration Dataset 1, Figure 5 ) that were kidney specific were validated in the independent set using qPCR reactions ( Figure S6 ).
Persistent Dme associated with progression of allografts to chronic renal allograft dysfunction DNAm status of the Pre-KT implant biopsies of both IFTA and NFA was determined also using Infinium Human Methylation 450K bead arrays. The 5% most variable CpG sites were retained (as described in Methods) and used to run unsupervised PC analysis algorithm between the four groups (Section A; Figure 1 ): Pre-KT biopsies (n = 40) (classified as in Results section 3.1), IFTA at >24 months (n = 18) and NFA at >24 months (n = 18) ( Figure 7 ). The IFTA samples classified together and independently from all the other samples. Interestingly, the NFA biopsies collected >24 months post-KT appear more similar to the Pre-KT biopsies ( Figure 7) . Also, the majority of the Pre-KT biopsies classified as IFTA at 24 months Post-KT were closer to the Post-KT IFTA and to the Post-KT NFA samples than those Pre-KT biopsies Figure 6 : Integration of three molecular layers and validations. The effect of DNA methylation on downstream gene and miRNA expression was studied by assessing sequential data integration at three levels: DNA methylation, miRNA, and GE. This gene set filtered after integration was seen to be involved in cell death and development disorder, especially in growth failure and dysgenesis of organs (A). The three miRNA and coexpression of their gene targets were validated using qPCR in training (B) and independent sets (C) of IFTA (n = 12) and NFA (n = 11)samples. The DCt values were plotted using scatterplot. The bar plot represents average datapoint. Student t-test was used (*p-value 0.05-0.01; **p-value 0.01-0.001; ***p-value ≤ 0.001). IFTA, interstitial fibrosis and tubular atrophy; NFA, stable functioning allograft with no or minimal IFTA; qPCR, quantitative polymerase chain reaction.
classified as NFA at 24 months Post-KT. Additionally, unsupervised cluster analysis was done and the heatmap with dendrograms is provided as Figure S7 . It can be noted that DNA modifications observed in IFTA samples occurred post-KT and were not present in paired preimplantation biopsies. The modifications observed were disease specific and stronger than the biological patient background (i.e. samples clustered separately [ Figure S7] ). Also, it was observed that qualitatively, DNA modifications were lower among NFA samples. However, these detected modifications similarly occurred post-KT and paired pre-KT from NFA samples (i.e. clustered separately but under the same main cluster, Figure S7 ).
Discussion
The progressive decline in kidney graft function with subsequent graft loss is characterized histologically by the development of IFTA, regardless of the initial source of injury. However, the factors that mediate advancement of initial graft injury to end-stage disease remain incompletely understood. Similar to wound repair, fibrosis is a process triggered by injury and characterized by the deposition of extracellular matrix through activated fibroblasts. However, in contrast to wound repair, fibrogenesis can progress even after the initiating insult has disappeared. The mechanisms that contribute to the maintenance of the profibrotic environment have not been well delineated, and may involve epigenetic modification of GE.
Recent reports have demonstrated an association between epigenetic modifications and CKD (28) . Most of these studies apply a methodology/approach that is too restrictive in scope, or utilizes systemic sampling (peripheral blood), which obscures the epigenetic modifications that are tissue specific. Currently, there is a research gap concerning the role of epigenetic modifications in chronic renal allograft dysfunction, the CKD equivalent in kidney transplantation. Additionally, the relationship between epigenetic changes and GE as cause and effect has not yet been fully explored, and represents a new and complex area of investigation with high relevance in the understanding of complex diseases. In the current pilot study, we evaluated a possible role of epigenetic modifications in molecular graft pathways that contribute to fibrosis development leading to loss of graft function. Using an integrative multiomic approach, three molecular layers of GE control were evaluated in kidney graft samples with IFTA to further understand the underlying mechanisms of fibrosis development.
DNAm was initially described as an epigenetic genesilencing mark several decades ago; however, since the advent of genome-scale technologies, this traditional view has been evolving (54) . The emerging information suggests that the function of DNAm may vary depending upon the context, with evidence to suggest the position of DNAm relative to the transcriptional unit may affect gene activity in different ways. DNAm at the TSS inhibits the binding of DNA polymerase or transcription factors, and hence gene transcription. The role of DNAm within the gene body is poorly understood, with evidence for both positive and negative correlations with transcription.
Based on these concepts, we followed careful sequential analyses in our study. First, after evaluating DNAm patterns between IFTA and NFA samples, we analyzed the distribution pattern of the Dme CpG sites along the regulatory features and chromosomes. Chromosome enrichment of the CpG sites was observed and the most significant was the association of hypermethylated sites at the chromosome 7p15 region ( Figure 2C ). The identified CpGs represent a cluster of homeobox genes (HOXA10, HOXA2, HOXA3, HOXA4 , and HOXA5) (www.atlasgeneticsoncology.org) (55) , which are DNA binding transcription factors known to function in GE, morphogenesis, and differentiation during development. They have been extensively studied in hematopoiesis (56) , but their regulatory role in the adult kidney has also been reported in cell culture models for cancer (57) . Considering the process of active cell death in the kidney graft with IFTA (58), methylation status of these genes could partly facilitate the process.
The distribution of the Dme CpG sites was mostly identified in the intergenic regions or the open sea ( Figure S1 ), where consistently higher variably methylated CpGs are more often reported (59) . These intergenic regions serve as a runway for transcription factors to bind to the transcription site (60) and activate GE. Consequently, their valuable role in GE regulation deserves further exploration.
The distribution of CpG sites in the promoter-associated regions was more important in the CpG island shore regions ( Figure S1B ), reported to be dynamic and highly correlated with GE changes (61, 62) . Furthermore, hypoand hypermethylated CpG sites were strongly enriched in intragenic protein-coding gene bodies (Figure 2A ). There are reports linking these sites to tissue-specific enhancers (63, 64) , while few studies show that these sites are responsible for tissue-specific spatiotemporal regulation of GE during development (60, 65) . Interestingly, in this study tissue-specific enhancer enrichment analysis showed immune cell specificity for the hypomethylated CpG sites, while hypermethylated sites were associated with homeostasis and structural maintenance of the adult kidney ( Figure 2B ) as discussed further below.
At the biological level, the genes annotated to hypo-and hypermethylated CpG sites are in concordance with enrichment analysis stated above. The hypomethylated CpGs sites corresponded to T helper cell activation, maturation, proliferation, and survival. Other sites corresponded to maturation of antigen-presenting cells such as macrophages and dendritic cells. Hypomethylation of genes including LCK, CD80, and CD86 involved in activation of CD8 and CD4 positive T cells and MHC genes (especially Class-II genes, including HLA-DMA, HLA-DMB, HLA-DOB, HLA-DPA1, and HLA-DRA1, among others) was observed. Instead, hypermethylated CpG sites were related to metabolic functions, integrity, and structure of kidney: (1) genes associated with ion channels (i.e. ENaC, Na+/H+ antiporter), as well as genes in the aldosterone signaling pathway in epithelial cells; and (2) genes involved in the PCP pathway, which participate in the maintenance of podocytes, repair of tubules and glomerulus, and preservation of glomerulus filtration barrier (66), including DVL, DAAM1, FZD, WNT, and CELSR. Although the described characteristic DNAm patterns have been further corroborated downstream with similar pathways seen differentially expressed in the same samples, our initial observations were done mainly to evaluate the overall distribution of Dme CpGs across genes.
While we recognize that the role of DNAm may extend beyond regulating gene transcription, we were mainly interested in the likely consequences for GE. To that end, direct examination of genome-wide expression was implemented to assess functional relevance. The overall directionality matching GE with methylation was 31.3%, implying the probable extent of DNAm-mediated regulation of GE. The hypomethylated and highly expressed genes were mostly immune cell related and might represent the effect of the continued host immune response to the graft in grafts progressing to CRAD. The cumulative function of these integrated genes is predicted to activate injury in the kidney. This includes genes such as CCR1, CD44, ICAM1, and STAT4 involved in recruitment of immune cells and thereby exacerbating kidney injury. The role of the complement system in long-term kidney injury was also observed with genes such as C3AR1, C5AR1, and FCGR2A. Because of the observed hypomethylation of the complement receptors, they could be constitutively expressed on macrophages and CD4+ T cells and stimulate maturation, cytokine production, and costimulatory molecule expression (67) . In addition to immune-mediated damage, genes such as FABP1 and Proc that have been previously shown to have protective function and recovery in kidney postischemic injury (68) (69) (70) were hypermethylated (DNAm array) and downregulated (mRNA array). We acknowledge that the kidney graft samples represent a heterogeneous system, include a mix of structural kidney cells, resident APC from donor kidney, and infiltrating cells from the host. This issue will influence every study evaluating kidney graft biopsies, independently of the methodology being applied or the analyses performed. However, the multi-omic approach and integrative analyses including gene enrichment provide a unique opportunity to evaluate the immune response of the host to the graft and the answer of the donor kidney to the injury.
A complex epigenetic network exists whereby even miRNA expression is under epigenetic control (71) . To further explore whether DNAm could regulate GE indirectly, via regulation of miRNA, we added another step to the integration. We have identified genes that were regulated by hypomethylated miRNAs (in the TSS region). Most of these genes were related to metabolomic processes and were notably downregulated. For instance, PPMIH dephosphorylates SMAD1/5/8 and attenuates BMP signaling. It has been reported that downregulation of this gene results in enhanced bone morphogenetic protein (BMP)-mediated cell signaling and mesenchymal differentiation (72) . Similarly, TGFBR3 was reported to inhibit the TGF-b signaling pathway, which is usually associated with increased extracellular matrix production, mesenchymal transition of cells (73) . G6PC deficiency is associated with oxidative stress, interstitial fibrosis, and nephromegaly (74) . Loss of function mutations of a few of the genes that were critically downregulated has been linked to renal abnormalities during development, implying their role in kidney function. CLCNKB, a voltage-gated chloride channel in the distal tubules, is an example (75) that was present on chromosome 1p36 region, which is highlighted by enrichment analysis of the hypermethylated CpGs from the present study, and interestingly a rare chromosome 1p36 deletion syndrome is associated with developmental defects that includes renal anomalies. NTRK2 is yet another down regulated gene, SNPs in this gene have been attributed to heritability of eGFR, implying its role in renal function/dysfunction (76) . ARHGAP24 mutation is associated with focal segmental glomerulosclerosis, because its loss of function results in dysfunction of podocytes (77) . In summary, the genes that were downregulated by DNAm or by a concerted effort of DNAm and miRNA, have important roles in maintaining functional and structural homeostasis of the kidney. Allografts with differential DNAm patterns could affect the wound-healing process profoundly and result in progression to IFTA.
The mechanisms elucidated above show DNAm of CpG sites as a possible cause for exacerbated immunemediated damage and decreased metabolism in the kidney graft during continuous graft injury, leading to chronic dysfunction. However, despite the robustness of the identified findings, the exact cause of this differential DNAm and the time when this change is apparent is not clear. Consequently, additional mechanistic studies are needed to validate these interactions.
Furthermore, when the only publicly available DNAm data from kidney (microdissected tubules) of diabetic CKD (DKD) biopsies (GSE50874) (27) were comparatively analyzed with our allograft biopsies with IFTA, overlap of gene methylation patterns was observed. Genes such as SMAD 6 and SMAD 3, which were reported to be critical for the TGF-b signaling pathway and DKD development, were also Dme in IFTA samples. Similarly, RUNX1, which was reported to be Dme in tubules of DKD patients, and Col4A1, one of the collagen genes, were also among the common genes that we observed in renal allograft samples from patients with IFTA. Additionally, a number of genes involved in adaptive and innate immune inflammatory pathways (i.e. CD45/PTPRC, CD58, IRF8, BCL2, LCK, and LCP2, among others) were also present in the common gene list. This clearly shows overlap of mechanisms of fibrosis development in DKD kidneys and grafts with IFTA, supporting the hypothesis of common pathways associated with fibrogenesis.
The validation of best set of genes and miRNAs in the training and validation sets, and the overlap of gene sets with previous published genes associated with IFTA (58, 78) show the reproducibility of our results. This is particularly relevant considering that we focused our integrative validation on those miRNA sequences located close by the TSS, implying likely high impact on GE. Moreover, the validation of the coexpression of miRNAs and their target genes following the expected biological expression direction in training and validation sets implies a consistent upstream regulatory mechanism, which could be related to DNAm as shown in this integrative study.
To better understand whether the observed DNAm changes in the IFTA group were a consequence of the events occurring post-KT, we further extended the DNAm study to Pre-KT biopsies categorized as IFTA or NFA at >24 months Post-KT. To visualize the similarity of the individual cases in the dataset, all the CpG sites having a variance at or above the 95 th percentile were retained and used to run unsupervised PC analysis algorithm between the four groups (Section A; Figure 1 ). The IFTA samples were classified together and independently from all the other samples. Interestingly, the NFA biopsies collected >24 months Post-KT appear more similar to the Pre-KT biopsies (Figure 7) . A majority of the Pre-KT biopsies classified as IFTA at 24 months post-KT were closer to the Post-KT IFTA and to the Post-KT NFA samples than those Pre-KT biopsies classified as NFA at 24 months Post-KT. Also, a pattern (less drastic in the number of Dme CpG sites) was observed in Pre-KT biopsies classified as IFTA versus NFA at >24 months post-KT, indicating that DNAm patterns in the donor organ before transplant can already be critical in prediction of long-term outcomes.
Our findings demonstrate for the first time a possible critical relationship among epigenetic modifications and IFTA development, graft function, and interindividual variation on long-term outcomes. Strengths of our study include the evaluation of tissue-specific kidney graft DNAm patterns, use of integrative approaches using ex vivo data for same samples, independent validation of miRNA:mRNA interactions and main tissue-specific affected genes, strict cut-off criteria for identifying statistical and biological differences among groups, and well-selected samples from a large prospective cohort study with detailed phenotypic information. Limitations of the study mainly relate to the complexity associated with further validation of epigenetic modifications on GE and a relatively small sample size. A longitudinal large study is needed to deduce the sequential changes in DNAm pattern and their relationship with graft fibrosis progression. The current study represents the foundation for further evaluation of the role of epigenetic modifications on critical molecular pathways leading to graft injury and affecting long-term graft outcomes. Moreover, it might represent the basis for the evaluation of the role of epigenetics modifications in native kidneys progressing to CKD and other solid organs. 
